help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Conover, C. A.
Right arrow Articles by Bale, L. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Conover, C. A.
Right arrow Articles by Bale, L. K.

Endocrinology, Vol 136, 1403-1410, Copyright © 1995 by Endocrine Society


ARTICLES

Effect of glucocorticoid on insulin-like growth factor (IGF) regulation of IGF-binding protein expression in fibroblasts

CA Conover, JT Clarkson and LK Bale
Endocrine Research Unit, Mayo Clinic, Rochester, Minnesota 55905.

Insulin-like growth factor (IGF)-binding proteins (IGFBPs) can determine IGF biological competence at the cellular level. IGF-I itself has been shown to be an important peptide regulator of local IGFBP availability. Glucocorticoid also has major effects on IGFBP expression. In the present study, we assessed integrated IGF-I and glucocorticoid regulation of IGFBP messenger RNA (mRNA) and protein expression in two fibroblast model systems. In bovine fibroblasts, IGF- I treatment induced IGFBP-3 and IGFBP-5 mRNA and protein secretion, and had a moderate effect on IGFBP-4 expression. Dexamethasone had little effect on the IGF-induced increase in IGFBP-3, but completely blocked the increase in IGFBP-5 expression. Basal IGFBP-4 expression was inhibited by dexamethasone, and this effect was counteracted by IGF-I. IGFBP-2 expression did not vary with IGF-I or dexamethasone treatment in these cells; IGFBP-1 mRNA was not detectable, and IGFBP-6 mRNA was low and inconsistent. In human fibroblasts, IGF-I treatment increased levels of IGFBP-3 and decreased levels of IGFBP-4 without influencing mRNA expression. IGF-I also increased steady state levels of IGFBP-5 mRNA. Dexamethasone alone decreased IGFBP-3, IGFBP-4, and IGFBP-5 mRNA, but it had no significant effect on IGFBP-3, -4, or -5 expression in the presence of IGF-I. Human fibroblast IGFBP-6 expression was stable under the different culture conditions; IGFBP-1 and -2 mRNA were not detected. These data demonstrate that IGF peptide and glucocorticoid individually modulate IGFBP expression and indicate that glucocorticoid has distinct effects on IGF regulation of IGFBP depending upon the particular IGFBP and the underlying mechanism of IGF regulation. Bovine fibroblasts may provide a useful model system to probe the molecular mechanisms of IGFBP-3, -4, and -5 gene expression and regulation by IGF- I and glucocorticoid, whereas human fibroblasts may be suitable for studying posttranscriptional interactions.


This article has been cited by other articles:


Home page
Circ. Res.Home page
S. C. Harrington, R. D. Simari, and C. A. Conover
Genetic Deletion of Pregnancy-Associated Plasma Protein-A Is Associated With Resistance to Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice Challenged With a High-Fat Diet
Circ. Res., June 22, 2007; 100(12): 1696 - 1702.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Z. T. Resch, R. D. Simari, and C. A. Conover
Targeted Disruption of the Pregnancy-Associated Plasma Protein-A Gene Is Associated with Diminished Smooth Muscle Cell Response to Insulin-like Growth Factor-I and Resistance to Neointimal Hyperplasia after Vascular Injury
Endocrinology, December 1, 2006; 147(12): 5634 - 5640.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
J M Fleming, B J Leibowitz, D E Kerr, and W S Cohick
IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells
J. Endocrinol., July 1, 2005; 186(1): 165 - 178.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. C. Baege, G. L. Disbrow, and R. Schlegel
IGFBP-3, a Marker of Cellular Senescence, Is Overexpressed in Human Papillomavirus-Immortalized Cervical Cells and Enhances IGF-1-Induced Mitogenesis
J. Virol., June 1, 2004; 78(11): 5720 - 5727.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. M. Ongeri, Q. Zhu, M. F. Verderame, and J. M. Hammond
Insulin-Like Growth Factor-Binding Protein-3 in Porcine Ovarian Granulosa Cells: Gene Cloning, Promoter Mapping, and Follicle-Stimulating Hormone Regulation
Endocrinology, April 1, 2004; 145(4): 1776 - 1785.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
S. R. Edmondson, S. P. Thumiger, G. A. Werther, and C. J. Wraight
Epidermal Homeostasis: The Role of the Growth Hormone and Insulin-Like Growth Factor Systems
Endocr. Rev., December 1, 2003; 24(6): 737 - 764.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B.-K. Chen, K. M. Leiferman, M. R. Pittelkow, M. T. Overgaard, C. Oxvig, and C. A. Conover
Localization and Regulation of Pregnancy-Associated Plasma Protein A Expression in Healing Human Skin
J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4465 - 4471.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. YOSHIZAWA and D. R. CLEMMONS
Testosterone and Insulin-like Growth Factor (IGF) I Interact in Controlling IGF-Binding Protein Production in Androgen-Responsive Foreskin Fibroblasts
J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1627 - 1633.
[Abstract] [Full Text]


Home page
JCBHome page
N. Farrelly, Y.-J. Lee, J. Oliver, C. Dive, and C. H. Streuli
Extracellular Matrix Regulates Apoptosis in Mammary Epithelium through a Control on Insulin Signaling
J. Cell Biol., March 22, 1999; 144(6): 1337 - 1348.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. B. Lawrence, C. Oxvig, M. T. Overgaard, L. Sottrup-Jensen, G. J. Gleich, L. G. Hays, J. R. Yates III, and C. A. Conover
The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A
PNAS, March 16, 1999; 96(6): 3149 - 3153.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Rousse, D. Montarras, C. Pinset, and C. Dubois
Up-Regulation of Insulin-Like Growth Factor Binding Protein-5 Is Independent of Muscle Cell Differentiation, Sensitive to Rapamycin, But Insensitive to Wortmannin and LY294002
Endocrinology, April 1, 1998; 139(4): 1487 - 1493.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. R. Powell, F. Liu, B. K. Baker, R. L. Hintz, S. K. Durham, E. D. Brewer, J. W. Frane, B. Tonshoff, O. Mehls, A.-M. Wingen, et al.
Insulin-Like Growth Factor-Binding Protein-6 Levels Are Elevated in Serum of Children with Chronic Renal Failure: A Report of the Southwest Pediatric Nephrology Study Group
J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 2978 - 2984.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Duan, S. B. Hawes, T. Prevette, and D. R. Clemmons
Insulin-like Growth Factor-I (IGF-I) Regulates IGF-binding Protein-5 Synthesis through Transcriptional Activation of the Gene in Aortic Smooth Muscle Cells
J. Biol. Chem., February 23, 1996; 271(8): 4280 - 4288.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society